poisar

Stocks · News reference

TriSalus Life Sciences Affirms FY2026 Sales Guidance of $54.000M-$57.000M vs $52.396M Est

Aug 6, 2026, 8:13 PMBenzinga Newsdesk

TriSalus Life Sciences (NASDAQ:TLSI) affirms FY2026 sales outlook from $54.000 million-$57.000 million to $54.000 million-$57.000 million vs $52.396 million estimate.

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

TLSI
Source
benzinga
Observed
Aug 6, 2026, 8:13 PM
Checked
Aug 6, 2026, 8:13 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading